Showing 221-230 of 2148 results for "".
Molecular Imaging Biomarkers in Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/molecular-imaging-biomarkers-in-dementia/31729/Amyloid and tau PET imaging aids evaluation of patients suspected of having Alzheimer disease or other dementias.Brain Imaging in Differential Diagnosis of Dementia
https://practicalneurology.com/diseases-diagnoses/imaging-testing/brain-imaging-in-differential-diagnosis-of-dementia/31533/Imaging biomarkers hold the promise of earlier diagnosis that may lead to more effective treatment.Toward Precision Medicine for Genetic Epilepsies: Glucose Transporter Type 1 Deficiency Syndrome
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/toward-precision-medicine-for-genetic-epilepsies-glucose-transporter-type-1-deficiency-syndrome/32055/As we begin to understand the mechanisms of specific genetic epilepsies, tailored treatments have the potential to be transformative, as in GLUT1-DS.Cluster Headache Preventive Therapies
https://practicalneurology.com/diseases-diagnoses/headache-pain/cluster-headache-preventive-therapies/31520/The challenges of cluster headache lead to treatments and further understanding.Opportunities and Challenges in the Treatment of Pediatric-Onset Multiple Sclerosis with Highly Active Disease-Modifying Therapies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/opportunities-and-challenges-in-the-treatment-of-pediatric-onset-multiple-sclerosis-with-highly-active-disease-modifying-therapies/32080/Clinical research aims to identify safer and more effective treatments for the overlooked population of children and adolescents with multiple sclerosis.Porphyric Neuropathy
https://practicalneurology.com/diseases-diagnoses/neuromuscular/porphyric-neuropathy/31689/Timely diagnosis and treatment and new medications to prevent attacks provide more options for treating acute hepatic porphyrias.Care of Individuals with Neurofibromatosis Type 1 Amid an Evolving Paradigm of Therapeutic Development
https://practicalneurology.com/diseases-diagnoses/neuro-oncology/care-of-individuals-with-neurofibromatosis-type-1-amid-an-evolving-paradigm-of-therapeutic-development/35583/Treatment for individuals with neurofibromatosis type 1, a complex disease with variabilities in presentation and disease course, requires a multidisciplinary approach with emphasis on surveillance along with ongoing discussion of therapeutic interventions.Spotlight on Sleep: Sound Sleep in the Intensive Care Unit: Source–Path–Receiver Model
https://practicalneurology.com/diseases-diagnoses/sleep/spotlight-on-sleep-sound-sleep-in-the-intensive-care-unit-source-path-receiver-model/32048/Providers know noise is a problem in the ICU; optimizing care in this environment requires knowledge of 3 key acoustics principles.Adult Inflammatory Myopathies: Updates on Classification and Management
https://practicalneurology.com/diseases-diagnoses/neuromuscular/adult-inflammatory-myopathies-updates-on-classification-and-management/32123/The inflammatory myopathies are classified into homogeneous subtypes on the basis of specific autoantibodies, and management strategies continue to evolve rapidly.COVID-19 & Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/covid-19-stroke/31740/COVID-19 has brought significant changes in stroke presentations, systems of care, and resource availability.